Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Total debt
Waters Corporation's total debt at the end of fiscal 2025 was $947.4M, down 41.7% from $1.6B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $4.9B. Over the past ten years it has ranged from $947.4M (fiscal 2025) to $2.3B (fiscal 2023) — the current reading is the lowest in ten years. Waters Corporation ranks 6th of 50 Diagnostics & Research companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $947.4M | (41.75%) |
| FY2024 | $1.6B | (29.45%) |
| FY2023 | $2.3B | 51.19% |
| FY2022 | $1.5B | 0.73% |
| FY2021 | $1.5B | 25.47% |
| FY2020 | $1.2B | (23.68%) |
| FY2019 | $1.6B | 37.68% |
| FY2018 | $1.1B | (39.49%) |
| FY2017 | $1.9B | 11.49% |
| FY2016 | $1.7B | 13.99% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $4.9B | 0.64% |
| Mar 2026 | $4.9B | 412.67% |
| Dec 2025 | $947.0M | (0.02%) |
| Sep 2025 | $947.2M | (20.87%) |
| 42 more quarters | Free account |
Against its own ten years
Low $947.4M
High $2.3B
Ten-year median
$1.5B
Current reading's percentile
9
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.0B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| WAT Waters Corporation | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| GH Guardant Health, Inc. compare | $1.5B |
| ILMN Illumina, Inc. compare | $1.5B |
| IDXX IDEXX Laboratories, Inc. compare | $449.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement